Historical salary details - Mr. John P. Schmid, Lead Independent Director, Poseida Therapeutics Inc
Mr. John P. Schmid is the Lead Independent Director of Poseida Therapeutics Inc.
Mr. John P. Schmid
Lead Independent Director
-
Gross Remuneration
-
Current Company
Poseida Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Poseida Therapeutics Inc | Lead Independent Director | - | - |
| 2024 | Design Therapeutics Inc | Independent Director | - | - |
| 2024 | Xeris Biopharma Holdings Inc | Lead Independent Director | - | - |
| 2024 | AnaptysBio Inc | Independent Director | - | - |
| 2024 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | AnaptysBio Inc | Independent Director | 335.4 K | 25.8 % |
| 2023 | Xeris Biopharma Holdings Inc | - | 218.3 K | 34.5 % |
| 2023 | Poseida Therapeutics Inc | Lead Independent Director | 175.1 K | 9.8 % |
| 2023 | Design Therapeutics Inc | Independent Director | 106.7 K | -40.2 % |
| 2022 | AnaptysBio Inc | Independent Director | 266.6 K | -11.3 % |
| 2022 | Design Therapeutics Inc | Independent Director | 178.5 K | -24.5 % |
| 2022 | Xeris Biopharma Holdings Inc | Lead Independent Director | 162.2 K | 54.4 % |
| 2022 | Poseida Therapeutics Inc | Lead Independent Director | 159.5 K | -53.5 % |
| 2022 | Helix Acquisition Corp. II - Ordinary Shares - Class A | Independent Director | - | - |
| 2021 | Poseida Therapeutics Inc | Lead Independent Director | 342.8 K | 25.7 % |
| 2021 | AnaptysBio Inc | Independent Director | 300.6 K | 55.6 % |
| 2021 | Design Therapeutics Inc | Independent Director | 236.4 K | 35.6 % |
| 2021 | Xeris Biopharma Holdings Inc | Lead Independent Director | 105.1 K | -4.7 % |
| 2020 | Poseida Therapeutics Inc | Independent Director | 272.8 K | 53.1 % |
| 2020 | AnaptysBio Inc | Independent Director | 193.2 K | -37.9 % |
| 2020 | Design Therapeutics Inc | Independent Director | 174.3 K | - |
| 2020 | Xeris Biopharma Holdings Inc | Lead Independent Director | 110.2 K | -42.7 % |
| 2019 | AnaptysBio Inc | Independent Director | 311.0 K | -29.2 % |
| 2019 | Xeris Biopharma Holdings Inc | Lead Independent Director | 192.4 K | -14.4 % |
| 2019 | Poseida Therapeutics Inc | Independent Director | 178.2 K | - |
| 2018 | AnaptysBio Inc | Independent Director | 438.9 K | 65.1 % |
| 2018 | Xeris Biopharma Holdings Inc | Independent Director | 224.8 K | 1210.0 % |
| 2017 | AnaptysBio Inc | Independent Director | 265.8 K | 564.6 % |
| 2017 | Xeris Biopharma Holdings Inc | Independent Director | 17.2 K | - |
| 2016 | AnaptysBio Inc | Director | 40 K | - |